Share this article
Share this article
ResearchAndMarkets.com's offering.
The US Lymphedema market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2020-2024). The market is expected to be driven by various growth-enhancing factors such as growing prevalence of breast cancer, increasing obesity, rise in urban population, escalating healthcare expenditure, rising prevalence of arthritis, and surge in the disposable income.
However, the market is not free from challenges that are hindering its growth. Some major challenges faced by the market are high cost involved, improvement in cancer treatment, and lack of awareness.